· Published by Health Canada · Official notice
These products are not authorized for sale in Canada and have not been found in the Canadian marketplace, but it is possible they may have been brought into the country by travellers or purchased over the Internet.
These products are promoted for weight loss.
The United States Food and Drug Administration (US FDA) warned consumers not to use these products after they were found to contain sibutramine.
Sibutramine was previously used to treat obesity but is no longer authorized for sale in Canada because of its association with an increased risk of cardiovascular side effects such as heart attack and stroke.
Unknown.
In addition to heart attack and stroke, side effects associated with sibutramine include increased blood pressure and heart rate, dry mouth, difficulty sleeping and constipation.
These products are promoted for weight loss.
The United States Food and Drug Administration warned consumers not to use these products after they were found to contain sibutramine and phenolphthalein.
Unknown
In addition to heart attack and stroke, side effects associated with sibutramine include increased blood pressure and heart rate, dry mouth, difficulty sleeping and constipation.
Additional side effects, associated with phenolphthalein include decreased blood pressure, skin rash, and gastrointestinal bleeding.
This product is promoted for weight loss.
The United States Food and Drug Administration warned consumers not to use this product after it was found to contain sibutramine and phenolphthalein and sildenafil.
Sibutramine was previously used to treat obesity but is no longer authorized for sale in Canada because of its association with an increased risk of cardiovascular side effects such heart attack and stroke.
In addition to heart attack and stroke, side effects associated with sibutramine, include increased blood pressure and heart rate, dry mouth, difficulty sleeping and constipation.
Additional side effects, from phenolphthalein, include decreased blood pressure, skin rash, and gastrointestinal bleeding.
Sildenafil should not be used by individuals taking any kind of nitrate drug (e.g., nitroglycerine) as it can cause potentially life-threatening low blood pressure. Individuals with heart problems are at increased risk of cardiovascular side-effects such as heart attack, stroke, chest pain, high blood pressure and abnormal heartbeat. Other side-effects include headache, facial flushing, indigestion, dizziness, abnormal vision, and hearing loss.
Health Canada advises Canadians to contact the Health Products and Food Branch Inspectorate at 1-800-267-9675 if they find the products listed above in the Canadian marketplace.
Canadians who have these products are advised not to use them, and should consult with a healthcare professional if they have concerns about their health related to the use of these products.
Drugs and natural health products that are authorized for sale in Canada will have an eight-digit Drug Identification Number (DIN), a Natural Product Number (NPN) or a Homeopathic Medicine Number (DIN-HM) on the label. These numbers indicate that the products have been assessed by Health Canada for safety, effectiveness and quality.
As of April 30, 2014, no adverse reactions suspected to be associated with the use of these products have been reported to Health Canada.
To report a side effect to a health product to Health Canada: